Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model
Experimental evidence suggests that oxidative and nitrative mechanisms account for much of the dopaminergic neuronal injury in Parkinson’s disease (PD). The ubiquitously expressed non-receptor tyrosine kinase c-Abl is activated by oxidative stress and thus, may play a role in redox-mediated neurodeg...
Main Authors: | Imam, Syed Z., Trickler, William, Kimura, Shinya, Binienda, Zbigniew K., Paule, Merle G., Slikker, William, Li, Senlin, Clark, Robert A., Ali, Syed F. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669292/ |
Similar Items
-
c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
by: Lindholm, Dan, et al.
Published: (2016) -
Molecular Aspects of Dopaminergic Neurodegeneration: Gene-Environment Interaction in Parkin Dysfunction
by: Ali, Syed F., et al.
Published: (2011) -
Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
by: Sarkar, Sumit, et al.
Published: (2016) -
Protein Kinases and Parkinson’s Disease
by: Mehdi, Syed Jafar, et al.
Published: (2016) -
Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
by: Okabe, Seiichi, et al.
Published: (2013)